Surrogate endpoints for clinical trials in non-alcoholic steatohepatitis

Lancet Gastroenterol Hepatol. 2017 Aug;2(8):549-550. doi: 10.1016/S2468-1253(17)30184-X.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers*
  • Humans
  • Liver
  • Non-alcoholic Fatty Liver Disease*

Substances

  • Biomarkers